Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
Introduction. There has been a recent trend toward a gradual increase in the incidence of rectal cancer and a decrease in the average age of patients. These changes interpret the need to personalize treatment in each case.Objective – to evaluate the association of polymorphic variants of some genes...
Saved in:
| Main Authors: | V. A. Grigorenko, E. P. Kulikov, S. A. Mertsalov, Yu. D. Kaminsky, A. A. Nikiforov, A. I. Sudakov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-07-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/355 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01) -
Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01) -
The Influence of Neoadjuvant Chemoradiotherapy on Muscle Mass in Patients with Rectal Cancer
by: Gregory Simpson, et al.
Published: (2019-07-01) -
Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
by: Nai-Yu Lin, et al.
Published: (2025-07-01) -
Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
by: Rongxin Zhang, et al.
Published: (2025-08-01)